Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics

被引:4
|
作者
Sterns, Laurence D. [1 ,6 ]
Auricchio, Angelo [2 ]
Schloss, Edward J. [3 ]
Lexcen, Dan [4 ]
Jacobsen, Luke [4 ]
DeGroot, Paul [4 ]
Molan, Amy [4 ]
Kurita, Takashi [5 ]
机构
[1] Vancouver Isl Arrhythmia Clin, Victoria, BC, Canada
[2] Ist Cardioctr Ticino, Div Cardiol, Lugano, Switzerland
[3] Christ Hosp, Cincinnati, OH USA
[4] Medtronic Inc, Mounds View, MN USA
[5] Kindai Univ, Sch Med, Dept Med, Div Cardiol, Osaka, Japan
[6] 300-3680 Uptown Blvd, Victoria, BC V8Z 0B9, Canada
关键词
Antitachycardia pacing; Implantable cardioverter-defi-brillator; Cardiac resynchronization therapy; defibrillator; Shock reduction; Device programming; FAST VENTRICULAR-TACHYCARDIA; LONG-DETECTION INTERVAL; QUALITY-OF-LIFE; PREVENTION PATIENTS; UNNECESSARY SHOCKS; MULTIPLE BURSTS; INAPPROPRIATE; REDUCTION; THERAPIES; EFFICACY;
D O I
10.1016/j.hrthm.2022.10.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Antitachycardia pacing (ATP) is an established implantable cardioverter-defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD shocks. However, factors influencing ATP success are not well understood.OBJECTIVE The purpose of this study was to examine ATP success rates by patient, device, and programming characteristics.METHODS This retrospective analysis of the PainFree SmartShock Technology study included spontaneous ATP-treated monomorphic VT episodes. ATP success rates were calculated for various factors. Also, the relationship of ATP programming on shock burden and syncope were investigated.RESULTS Of the 2770 enrolled patients (2200 [79%] male; mean age 65 years), 1699 (61%) received an ICD and 1071 (39%) a car-diac resynchronization therapy - defibrillator. ATP had .80% rate of success for terminating VTs overall, with similar rates observed between ICD and cardiac resynchronization therapy - defibrillator devices (82.2% vs 80.3%, respectively; P = .81) as well as between primary and secondary prevention patients with ICDs (77.2% vs 83.9% respectively; P = .25). Arrhythmias with a median cycle length of >320 ms had a significantly higher ATP success rate (88.0%; 95% confidence interval 84.8%-90.6%). The cumulative percentage of ATP success increased from 71% at 1 ATP sequence delivered to 87% at >8 sequences delivered. Programming more ATP sequences was associated with lower shock burden (P = .0005). There was no evidence that more sequences were associated with higher rates of syncope (P = .16).CONCLUSION Delivering more ATP sequences resulted in a higher overall success of terminating VTs, while programming more ATP was associated with decreased shock burden and no evidence of increased syncope or acceleration. This suggests that more ATP se-quences should be programmed when possible, but confirmation in prospective studies will be necessary.
引用
收藏
页码:190 / 197
页数:8
相关论文
共 50 条
  • [1] Efficacy of antitachycardia pacing in hypertrophic cardiomyopathy with implantable cardioverter-defibrillators
    Lee, C. H.
    Kim, S.
    Choi, H. O.
    Kim, K. H.
    Nam, G.
    Choi, K.
    Kim, Y.
    [J]. EUROPEAN HEART JOURNAL, 2011, 32 : 921 - 921
  • [2] Multiple attempts of antitachycardia pacing are useful in implantable cardioverter-defibrillators
    Schaumann, A
    Poppinga, A
    Neufert, C
    Fabian, O
    Herse, B
    Unterberg, C
    Kreuzer, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 434A - 434A
  • [3] Antitachycardia pacing in patients with implantable cardioverter-defibrillators: Inverse circadian variation of therapy success and acceleration
    Fries, R
    Heisel, A
    Nikoloudakis, N
    Jung, J
    Schafers, HJ
    Schieffer, H
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11): : 1487 - 1489
  • [4] ANTITACHYCARDIA PACING AND IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    FURMAN, S
    MERCANDO, AD
    [J]. ANNUAL REVIEW OF MEDICINE, 1989, 40 : 123 - 136
  • [5] IS ANTITACHYCARDIA PACING REALLY AN ADVANTAGE IN PATIENTS WITH CARDIOVERTER-DEFIBRILLATORS
    TRAPPE, HJ
    KLEIN, H
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, : A205 - A205
  • [6] Empirically programmed antitachycardia pacing in implantable cardioverter-defibrillators: A prospective study in 172 patients
    Schaumann, A
    vonzurMuehlen, F
    Gonska, BD
    [J]. CIRCULATION, 1996, 94 (08) : 1866 - 1866
  • [7] Implantable cardioverter-defibrillators, heart failure, and patient characteristics
    Stamato, Nicholas J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 285 - 285
  • [8] SAFETY OF ANTITACHYCARDIA PACING IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS AND SEVERELY DEPRESSED LEFT-VENTRICULAR FUNCTION
    HEISEL, A
    NEUZNER, J
    HIMMRICH, E
    PITSCHNER, HF
    LIEBRICH, A
    JUNG, J
    SEN, S
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (01): : 137 - 141
  • [9] Implantable cardioverter-defibrillators, heart failure, and patient characteristics - Reply
    Hernandez, Adrian F.
    Fonarow, Gregg C.
    Peterson, Eric D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (03): : 286 - 286
  • [10] TREATMENT OF VENTRICULAR TACHYARRHYTHMIAS IN PATIENTS WITH IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS AND ANTITACHYCARDIA PACEMAKERS
    WINTERS, SL
    CAMUNAS, J
    ERGIN, A
    ESTIOKO, M
    GOMES, JA
    [J]. CURRENT OPINION IN CARDIOLOGY, 1989, 4 (04) : 555 - 558